Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02702843 · ClinicalTrials.gov registry record · NA

Fluorescent Cholangiography vs White Light for Bile Ducts Identification

A NA study, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
677
Enrollment target

NCT02702843 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 677 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02702843, a NA study, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
677 participants
Enrollment target

Study Summary

The Study is designed to compare the effectiveness of Near Infrared Fluorescence Cholangiography (NIFC) to standard white light imaging (WLI) in visualizing and identifying the main biliary and hepatic structures (Cystic Duct, Right Hepatic Duct, Common Hepatic Duct, Common Bile Duct, Cystic-CBD junction, Cystic-Gallbladder junction and any Accessory Ducts) during laparoscopic cholecystectomy. The aim is to demonstrate that NIFC performs better than standard white light (WLI) alone in visualizing and identifying extra-hepatobiliary structures (Cystic Duct, Right Hepatic Duct, Common Hepatic Duct, Common Bile Duct, Cystic-CBD junction, Cystic-Gallbladder junction, and any Accessory Ducts) before and after dissection during Laparoscopic Cholecystectomy (LC).

Interventions

  • PROCEDURE Laparoscopic cholecystectomy with Xenon light
  • PROCEDURE Laparoscopic cholecystectomy (fluorescent cholangiography)

Trial Details

FieldValue
Enrollment Target 677 participants
Start Date 2016-04
Est. Completion 2018-08-31
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT02702843

The ClinicalTrials.gov registry entry for NCT02702843 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 677 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Laparoscopic cholecystectomy with Xenon light is the first listed.

NCT02702843 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02702843 about?

NCT02702843 is a clinical study titled "Fluorescent Cholangiography vs White Light for Bile Ducts Identification". The Study is designed to compare the effectiveness of Near Infrared Fluorescence Cholangiography (NIFC) to standard white light imaging (WLI) in visualizing and identifying the main biliary and hepatic structures (Cystic Duct, Right Hepatic Duct, Common Hepatic Duct, Common Bile Duct, Cystic-CBD jun...

What is the current status of trial NCT02702843?

This trial is currently completed. It is a NA study. The enrollment target is 677 participants. The study started on 2016-04. Estimated completion is 2018-08-31.

What interventions are being tested in trial NCT02702843?

The interventions under investigation include: Laparoscopic cholecystectomy with Xenon light (PROCEDURE), Laparoscopic cholecystectomy (fluorescent cholangiography) (PROCEDURE).

Who is sponsoring clinical trial NCT02702843?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.